Orthobunyavirus Antibodies in Humans, Yucatan Peninsula, Mexico - - Emerging Infectious Disease journal - CDC
Dispatch
Orthobunyavirus Antibodies in Humans, Yucatan Peninsula, Mexico
Article Contents
Abstract
We performed a serologic investigation to determine whether orthobunyaviruses commonly infect humans in the Yucatan Peninsula of Mexico. Orthobunyavirus-specific antibodies were detected by plaque reduction neutralization test in 146 (18%) of 823 persons tested. Further studies are needed to determine health risks for humans from this potentially deadly group of viruses.CVV is a recognized human pathogen (5) that has been linked to severe encephalitis and multiorgan failure. KRIV has not been implicated as a cause of human disease, although antibodies to this virus have been detected in humans in Argentina (6). Recent data suggest that CHLV is a reassortant that acquired its small RNA segment from CVV and medium and large RNA segments from Potosi virus (POTV) (1). No clear evidence exists for human susceptibility to infection with CHLV or SOURV. However, diagnostic laboratories rarely test for orthobunyavirus infection; therefore, the true disease incidence and seroprevalence of these viruses remains to be determined. Because orthobunyaviruses comprise a neglected but potentially deadly group of viruses and recent studies have provided evidence of orthobunyavirus activity in the Yucatan Peninsula (1–4), we investigated whether orthobunyaviruses commonly infect humans in this region.
No hay comentarios:
Publicar un comentario